Medicines as a Service
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the...
-д хадгалсан:
| Үндсэн зохиолчид: | , , |
|---|---|
| Формат: | Online |
| Хэл сонгох: | англи |
| Хэвлэсэн: |
RAND Corporation
2023
|
| Нөхцлүүд: | |
| Онлайн хандалт: | ONIX_20231005_9780833076465_783 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
| _version_ | 1869524308788772864 |
|---|---|
| author | Mattke, Soeren Klautzer, Lisa Mengistu, Tewodaj |
| author_browse | Klautzer, Lisa Mattke, Soeren Mengistu, Tewodaj |
| author_facet | Mattke, Soeren Klautzer, Lisa Mengistu, Tewodaj |
| author_sort | Mattke, Soeren |
| collection | Directory of Open Access Books |
| description | The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. |
| format | Online |
| id | doab-20.500.12854ir-115009 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | RAND Corporation |
| publisherStr | RAND Corporation |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1150092024-04-01T14:14:59Z Medicines as a Service Mattke, Soeren Klautzer, Lisa Mengistu, Tewodaj Health Sciences thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. 2023-10-05T10:22:55Z 2023-10-05T10:22:55Z 2012 book ONIX_20231005_9780833076465_783 9780833076465 https://directory.doabooks.org/handle/20.500.12854/115009 eng image/jpeg n/a https://www.jstor.org/stable/10.7249/OP381HLTH RAND Corporation 10.7249/OP381HLTH 10.7249/OP381HLTH 47ac0b54-b121-491c-a9c8-5ca6776e27cb 9780833076465 open access |
| spellingShingle | Health Sciences thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Mattke, Soeren Klautzer, Lisa Mengistu, Tewodaj Medicines as a Service |
| title | Medicines as a Service |
| title_full | Medicines as a Service |
| title_fullStr | Medicines as a Service |
| title_full_unstemmed | Medicines as a Service |
| title_short | Medicines as a Service |
| title_sort | medicines as a service |
| topic | Health Sciences thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| topic_facet | Health Sciences thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| url | ONIX_20231005_9780833076465_783 |
| work_keys_str_mv | AT mattkesoeren medicinesasaservice AT klautzerlisa medicinesasaservice AT mengistutewodaj medicinesasaservice |